NEWS CENTER

15

2024-05

"Maker Beijing 2023" Innovation and Entrepreneurship Competition Haidian District level competition special prize

2024-05-15

"Maker Beijing 2023" Innovation and Entrepreneurship Competition Haidian District level competition special prize

15

2024-05

First prize in the Growth Group of the 11th China Innovation and Entrepreneurship Competition Beijing (2022)

2024-05-15

First prize in the Growth Group of the 11th China Innovation and Entrepreneurship Competition Beijing (2022)

15

2024-05

ToP10 of China Biomedical Technology Innovation Value List in 2022 (innovation Therapy List)

2024-05-15

ToP10 of China Biomedical Technology Innovation Value List in 2022 (innovation Therapy List)

15

2024-05

Top 50 Most Innovative Biopharmaceutical Enterprises in China

2024-05-15

Top 50 Most Innovative Biopharmaceutical Enterprises in China

15

2024-05

TOP10 of Zhongguancun International Frontier Science and Technology Innovation Competition in biomedicine field

2024-05-15

TOP10 of Zhongguancun International Frontier Science and Technology Innovation Competition in biomedicine field

15

2024-05

Beijing New-Tech & New-Product (Service) Certificate

2024-05-15

Beijing New-Tech & New-Product (Service) Certificate

09

2024-05

Nature Communications| Yang Liping's team and CHIGENOVO published the latest research results on gene therapy for crystalline retinal degeneration based on gene editing technology

Nature Communications| Yang Liping's team and CHIGENOVO published the latest research results on gene therapy for crystalline retinal degeneration based on gene editing technology

2024-05-09

Nature Communications| Yang Liping's team and CHIGENOVO published the latest research results on gene therapy for crystalline retinal degeneration based on gene editing technology

25

2024-04

Signal Transduction and Targeted Therapy| Yang Liping's team and CHIGENOVO published the results of the world's first clinical trial of gene replacement therapy for crystalline retinal degeneration

Signal Transduction and Targeted Therapy| Yang Liping's team and CHIGENOVO published the results of the world's first clinical trial of gene replacement therapy for crystalline retinal degeneration

2024-04-25

Signal Transduction and Targeted Therapy| Yang Liping's team and CHIGENOVO published the results of the world's first clinical trial of gene replacement therapy for crystalline retinal degeneration
< 12345 >
Medium cause

CHIGENOVO Co., Ltd. is an ophthalmic gene therapy company, a national high-tech enterprise focusing on genetic diagnosis of genetic eye diseases and the development of gene therapy drugs. It is committed to providing "one-stop" services for patients with genetic eye diseases.

HUATAO GROUP

Contact us

Telephone:400-6006223   010-82071936
Website:en.chinagene.cc
Address: Floor 4, Area D, Building 1, No.27 Life Garden Road, Zhongguancun Life Science Park, Changping District, Beijing

WeChat subscription account

Medium cause

Powered by www.300.cn | SEO

Business License